Old Web
English
Sign In
Acemap
>
authorDetail
>
Ron G Aoyama
Ron G Aoyama
Pharmacology
MAPK/ERK pathway
Biochemistry
Chemistry
Kinase
3
Papers
92
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Discovery of potent and selective inhibitors of calmodulin-dependent kinase II (CaMKII)
2017
Bioorganic & Medicinal Chemistry Letters
Dmitry Koltun
Eric Parkhill
Rao Kalla
Thao Perry
Elfatih Elzein
Xiaofen Li
Scott Preston Simonovich
Christopher Ziebenhaus
Timothy R. Hansen
Bruno Marchand
WaiLok K. Hung
Leanna Lagpacan
Magdeleine Hung
Ron G Aoyama
Bernard P. Murray
Jason Perry
John R. Somoza
Armando G. Villaseñor
Nikos Pagratis
Jeff Zablocki
Show All
Source
Cite
Save
Citations (4)
Bridging the Gap between Preclinical and Clinical Studies Using Pharmacokinetic–Pharmacodynamic Modeling: An Analysis of GDC-0973, a MEK Inhibitor
2012
Clinical Cancer Research
Harvey Wong
Laurent Vernillet
Amy C. Peterson
Joeseph A Ware
Lillian Lee
Jean-François Martini
Peiwen Yu
Congfen Li
Geoffrey Del Rosario
Edna F. Choo
Klaus P. Hoeflich
Yongchang Shi
Blake T. Aftab
Ron G Aoyama
Sanh Tan Lam
Marcia Belvin
John Prescott
Show All
Source
Cite
Save
Citations (61)
Preclinical Disposition of GDC-0973 and Prospective and Retrospective Analysis of Human Dose and Efficacy Predictions
2012
Drug Metabolism and Disposition
Edna F. Choo
Marcia Belvin
Jason Boggs
Yuzhong Deng
Klaus P. Hoeflich
Justin Ly
Mark Merchant
Christine Orr
Emile Plise
Kirk Robarge
Jean-François Martini
Robert Kassees
Ron G Aoyama
Atulkumar Ramaiya
Stuart Johnston
Show All
Source
Cite
Save
Citations (27)
1